| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535 |
| filingDate |
2001-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57fce5b8d781f76b116654dd89e90975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fc29757bdb1123823e4372165105663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6522a5b674691ef2e9228ed568a50582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2fdf8d91a5daf5e15cc846e3790a69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_786825bee3e68bafc53155d6a05b97ef |
| publicationDate |
2003-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003119875-A1 |
| titleOfInvention |
Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof |
| abstract |
The present invention is directed to pharmaceutical formulations containing 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene or a salt thereof; stabilized to oxidation or other forms of decomposition by incorporation of a stabilizing agent selected from methionine, acetylcysteine, cysteine or salts thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009076983-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009076983-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011036265-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2305238-A1 |
| priorityDate |
2000-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |